Andrew Cheng, President and CEO: Akero Therapeutics AKRO Sell · Filed 24/10/18

Trade details

Type: Insider sale
Amount: $1,996,258.89
Shares · price: 63,313 sh · $31.53 a share
Held after: 605,643 sh
Stock: Akero Therapeutics AKRO
Person: Andrew ChengPresident and CEO
Trade date: 24/10/18
Filed: 24/10/18
Days to filing: 0 days

Sold 9.5% of holdings

Share of holding sold: 9.5%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 24/09/18~24/11/17

Andrew Cheng's recent trades

Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$1.6M
30,000 sh
$1.6M
Filed 25/10/14
Traded 25/10/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$968.3K
22,525 sh
$968.3K
Filed 25/09/12
Traded 25/09/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$321.9K
7,317 sh
$321.9K
Filed 25/09/12
Traded 25/09/10
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$77.3K
1,796 sh
$77.3K
Filed 25/09/12
Traded 25/09/11
Andrew ChengPresident and CEO
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$7,050
158 sh
$7,050
Filed 25/09/12
Traded 25/09/10

Andrew Cheng, CEO — sold $2M of Akero Therapeutics AKRO · 9.5% of holdings · 10b5-1 plan | Whalegun